J. Muller-deile, K. Worthmann, and M. Saleem, The balance of autocrine VEGF-A and VEGF-C determines podocyte survival, AJP: Renal Physiology, vol.297, issue.6, pp.1656-1667, 2009.
DOI : 10.1152/ajprenal.00275.2009

F. Guan, G. Villegas, and J. Teichman, Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP, AJP: Renal Physiology, vol.291, issue.2, pp.422-428, 2006.
DOI : 10.1152/ajprenal.00448.2005

S. Ivy, J. Wick, and B. Kaufman, An overview of small-molecule inhibitors of VEGFR signaling, Nature Reviews Clinical Oncology, vol.15, issue.10, pp.569-579, 2009.
DOI : 10.1038/nrclinonc.2009.130

R. Kerbel, Tumor Angiogenesis, New England Journal of Medicine, vol.358, issue.19, pp.2039-2049, 2008.
DOI : 10.1056/NEJMra0706596

A. Maharaj, M. Saint-geniez, and A. Maldonado, Vascular Endothelial Growth Factor Localization in the Adult, The American Journal of Pathology, vol.168, issue.2, pp.639-648, 2006.
DOI : 10.2353/ajpath.2006.050834

G. Neufeld, T. Cohen, and S. Gengrinovitch, Vascular endothelial growth factor (VEGF) and its receptors, FASEB J, vol.13, pp.9-22, 1999.

D. Shweiki, A. Itin, and D. Soffer, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, vol.359, issue.6398, pp.843-845, 1992.
DOI : 10.1038/359843a0

M. Heinrich, C. Corless, and A. Duensing, PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors, Science, vol.299, issue.5607, pp.708-710, 2003.
DOI : 10.1126/science.1079666

. Proteinuria, 6-19.5) Edema 14 5 (62.5%) 4 (31%) Microhematuria 12 2 (28.5%) 6 (46%) SCr, mg/dL, mean (range) 1, pp.17-10245

M. Fsg, TM A , t h rom bot i c m i c r oa ng i opa t hy ; mRCC, metastatic renal cell carcinoma; IFN?, interferon alpha; VEGF, vascular endothelial growth factor; SBP, systolic blood pressure; DBP, diastolic blood pressure; SCr, serum creatinin; aMDRD CrCl, creatinine clearance; mo, month, pp.46-83